We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
-0.81%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$28.5B
AUM Growth
+$106M
Cap. Flow
-$77.3M
Cap. Flow %
-0.27%
Top 10 Hldgs %
12.78%
Holding
2,214
New
277
Increased
776
Reduced
718
Closed
342

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$129M
2
SBUX icon
Starbucks
SBUX
+$123M
3
EOG icon
EOG Resources
EOG
+$122M
4
CBRE icon
CBRE Group
CBRE
+$114M
5
A icon
Agilent Technologies
A
+$111M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$171M
2
AAPL icon
Apple
AAPL
+$143M
3
RY icon
Royal Bank of Canada
RY
+$114M
4
MRK icon
Merck
MRK
+$94.9M
5
TDY icon
Teledyne Technologies
TDY
+$93.1M

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 14.52%
3 Consumer Discretionary 12.47%
4 Financials 10.64%
5 Industrials 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOVO
1701
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$162K ﹤0.01%
+11,588
New +$156K
PBYI icon
1702
Puma Biotechnology
PBYI
$406M
$156K ﹤0.01%
+22,200
New +$166K
PLAB icon
1703
Photronics
PLAB
$1.79B
$151K ﹤0.01%
+11,130
New +$151K
WBD icon
1704
CALL
Warner Bros
WBD
$64.6B
$150K ﹤0.01%
+5,900
New +$166K
WBD icon
1705
PUT
Warner Bros
WBD
$64.6B
$150K ﹤0.01%
+5,900
New +$166K
ATEN icon
1706
A10 Networks
ATEN
$2.47B
$147K ﹤0.01%
10,888
+682
+7% +$8.84K
ADVM
1707
DELISTED
Adverum Biotechnologies
ADVM
$142K ﹤0.01%
6,559
-6,340
-49% -$162K
SCS
1708
DELISTED
Steelcase
SCS
$139K ﹤0.01%
10,953
-8,947
-45% -$123K
ABSI icon
1709
Absci
ABSI
$1.28B
$135K ﹤0.01%
+11,627
New +$226K
PAVM icon
1710
PAVmed
PAVM
$33.9M
$135K ﹤0.01%
+35
New +$110K
TALK icon
1711
Talkspace
TALK
$873M
$135K ﹤0.01%
+37,100
New +$204K
PXD
1712
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
$133K ﹤0.01%
+800
New +$121K
BOWXW
1713
DELISTED
BowX Acquisition Corp. Warrant
BOWXW
$132K ﹤0.01%
63,570
+18,580
+41% +$41.2K
ATRS
1714
DELISTED
Antares Pharma, Inc.
ATRS
$129K ﹤0.01%
35,400
+17,500
+98% +$70.8K
EAR
1715
DELISTED
Eargo, Inc. Common Stock
EAR
$126K ﹤0.01%
936
+58
+7% +$31K
CNDT icon
1716
Conduent
CNDT
$230M
$125K ﹤0.01%
+18,920
New +$130K
CVX icon
1717
CALL
Chevron
CVX
$388B
$122K ﹤0.01%
+1,200
New +$120K
CVX icon
1718
PUT
Chevron
CVX
$388B
$122K ﹤0.01%
+1,200
New +$120K
TOIIW
1719
The Oncology Institute Warrant
TOIIW
$120K ﹤0.01%
94,740
XLI icon
1720
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
$117K ﹤0.01%
1,200
-400
-25% -$41.1K
AKA icon
1721
a.k.a. Brands
AKA
$119M
$116K ﹤0.01%
+1,130
New +$129K
CAT icon
1722
CALL
Caterpillar
CAT
$409B
$115K ﹤0.01%
+600
New +$125K
CAT icon
1723
PUT
Caterpillar
CAT
$409B
$115K ﹤0.01%
+600
New +$125K
LEN icon
1724
CALL
Lennar Class A
LEN
$20.4B
$103K ﹤0.01%
1,136
+723
+175% +$71.5K
LEN icon
1725
PUT
Lennar Class A
LEN
$20.4B
$103K ﹤0.01%
1,136
+723
+175% +$71.5K

Similar funds

Man Group's Q3 2021 Portfolio in Review

As of Q3 2021, Man Group held 2,214 positions worth $28.5B, up 0.37% from $28.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Man Group's Q3 2021 filing shows 277 new, 776 increased, 718 reduced and 342 closed positions. Its largest new stake was Medallia, Inc.: 961,469 shares worth $32.6M. The largest sale was Amazon, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Man Group's largest Q3 2021 buy was Medallia, Inc.: 961,469 shares worth $32.6M.
  • Man Group added most to Mastercard in Q3 2021, an estimated $129M increase.
  • Man Group's biggest Q3 2021 reduction was Amazon, cutting an estimated $171M.
  • Man Group fully exited iShares MSCI Emerging Markets ETF in Q3 2021, selling an estimated $84M.
  • Man Group's ten largest holdings make up 13% of its $28.5B portfolio in Q3 2021.
  • Man Group opened 277 new positions and closed 342 in Q3 2021.
  • Man Group's portfolio value rose 0.37% quarter-over-quarter to $28.5B.

Based on Man Group's 13F filing for Q3 2021, filed 15 Nov 2021.